Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gee

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 28, 2015
Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomyJason R Gee, Daniel R Saltzstein, Edward Messing, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|February 19, 2019
Reduction in FSH Throughout the Menstrual Cycle After Omega-3 Fatty Acid Supplementation in Young Normal Weight but not Obese WomenJessica L Bauer, Katherine Kuhn, Andrew P Bradford, et al.
Urologic Oncology|May 5, 2010
BCAN Think Tank session 3: Prevention of bladder cancerSeth P Lerner, H Barton Grossman, Edward M Messing, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 23, 2017
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue BiomarkersJason R Gee, Daniel R Saltzstein, KyungMann Kim, et al.
Nuclear Medicine Communications|July 19, 2023
Brain PET and SPECT imaging and quantification: a survey of the current status in the UKSofia K Michopoulou, John C Dickson, Glen G Gardner, et al.
BMC Medical Research Methodology|May 14, 2026
Guidance for protocol content and reporting of dog-assisted interventions in randomised controlled trials: explanation and elaboration of the SPIRIT 2025 and CONSORT 2025 extensionsEmily Shoesmith, Elena Ratschen, Evgenia Riga, et al.
Journal of Clinical Pharmacy and Therapeutics|June 20, 2014
A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial)K Stewart, J George, K P Mc Namara, et al.
Translational Oncology|August 22, 2021
Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancerHester A Doyle, Renelle J Gee, Tyler D Masters, et al.
European Urology|October 23, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markersAshish M Kamat, Paul K Hegarty, Jason R Gee, et al.
The Journal of Urology|April 22, 2014
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsiesAlan W Partin, Leander Van Neste, Eric A Klein, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 28, 2015
Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomyJason R Gee, Daniel R Saltzstein, Edward Messing, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|February 19, 2019
Reduction in FSH Throughout the Menstrual Cycle After Omega-3 Fatty Acid Supplementation in Young Normal Weight but not Obese WomenJessica L Bauer, Katherine Kuhn, Andrew P Bradford, et al.
Urologic Oncology|May 5, 2010
BCAN Think Tank session 3: Prevention of bladder cancerSeth P Lerner, H Barton Grossman, Edward M Messing, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 23, 2017
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue BiomarkersJason R Gee, Daniel R Saltzstein, KyungMann Kim, et al.
Nuclear Medicine Communications|July 19, 2023
Brain PET and SPECT imaging and quantification: a survey of the current status in the UKSofia K Michopoulou, John C Dickson, Glen G Gardner, et al.
BMC Medical Research Methodology|May 14, 2026
Guidance for protocol content and reporting of dog-assisted interventions in randomised controlled trials: explanation and elaboration of the SPIRIT 2025 and CONSORT 2025 extensionsEmily Shoesmith, Elena Ratschen, Evgenia Riga, et al.
Journal of Clinical Pharmacy and Therapeutics|June 20, 2014
A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial)K Stewart, J George, K P Mc Namara, et al.
Translational Oncology|August 22, 2021
Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancerHester A Doyle, Renelle J Gee, Tyler D Masters, et al.
European Urology|October 23, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markersAshish M Kamat, Paul K Hegarty, Jason R Gee, et al.
The Journal of Urology|April 22, 2014
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsiesAlan W Partin, Leander Van Neste, Eric A Klein, et al.
Pageof 20